Increases in tumor markers are associated with primary Sjögren's syndrome-associated interstitial lung disease.

Shi, Lei; Han, Xiao-Lei; Guo, Hong-Xia; Wang, Jia; Tang, Yu-Ping; Gao, Chong; Li, Xiao-Feng

Shi, Lei; Han, Xiao-Lei; Guo, Hong-Xia; Wang, Jia; Tang, Yu-Ping; Gao, Chong; Li, Xiao-Feng.

Afiliação

Shi L; Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Han XL; Department of Mental Health, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Guo HX; Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Wang J; Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Tang YP; Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Gao C; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Li XF; Department of Rheumatology, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Xinghualing District, 030000, Taiyuan, Shanxi, China.

Ther Adv Chronic Dis ; 11: 2040622320944802, 2020.

Article em En | MEDLINE | ID: mdl-32843956

Palavras-chave

interstitial lung disease; primary Sjögren's syndrome; tumor markers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Ther Adv Chronic Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google